Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
ERock files initial beneficial ownership statement for Walter Thomas McAndrew Jr

ERock files initial beneficial ownership statement for Walter Thomas McAndrew Jr

ReutersReuters2026/09/05 00:36
  • ERock Form 3 disclosed Walter Thomas McAndrew Jr. as a 10% owner, tied to an event dated June 9, 2026.
  • Beneficial ownership reported: 6,368,562 Class B common shares held directly.
  • Indirect stake: 16,633,122 Class B common shares held via McAndrew Holdings, Ltd.
  • Derivative holdings: Class B Units exchangeable 1-for-1 into 6,368,562 Class A shares directly.
  • McAndrew Holdings, Ltd. held Class B Units exchangeable into 16,633,122 Class A shares indirectly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ERock Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041631), on September 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application

Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.

智通财经2026/09/05 01:16
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application